Success Stories: EB-1A Approved for a Postdoctoral Fellow in California in the Field of Pharmacology

Client’s Testimonial:

 

Thank you for your excellent work. I will definitely share my experience in http://www.mitbbs.com. [...]  Thanks again for all your help. You did a fantastic job.

 


On March 23rd, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Pharmacology (Approval Notice)


General Field: Pharmacology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: China

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: California

Approval Notice Date:  March 23rd, 2015

Processing Time:  19 days (7 days after Requesting Premium Processing)

 

 


Case Summary:

Our client in this case was a pharmacologist from China who had made numerous findings in the area of the cellular and molecular mechanisms of, and therapies for, various cardiovascular disorders.  Her work had resulted in 20 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that her case was filed, her publications had been cited at least 296 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work.  She had also reviewed 13 manuscripts for 8 distinctive, internationally-circulated journals. An independent recommender remarked upon her superior expertise: “Based on the best-in-class quality and originality of her research, I urge you to look upon [Client] favorably so that she can continue to do her groundbreaking work. She has proven herself repeatedly to be a first-rate scientist who is and will continue to be of significant benefit to the development of new treatments for cardiovascular disease.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Pharmacology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 19 days (7 days after requesting Premium Processing).